Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Looking for quick cash jobs near you? Discover local opportunities that can help you earn money fast.
25,479 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Silver miners surged 124% over the past year and platinum climbed 89%, but volatility has risen. Investors face a cle...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
This guide breaks down what Greenlight Re (GLRE) investors should watch in the first-quarter 2026 results. Learn how ...
Silver markets tighten as COMEX inventories shrink and the pricing curve tightens. Traders ask how long the exchange ...
Analysts warn that Iran could use control of key internet cables as a new economic lever, risking a wave of volatilit...
Wells Fargo analysts warn the AI investment surge resembles a euphoric bubble, advising investors to ride gains while...
With the 2026 World Cup drawing millions to North America, specific ETFs positioned benefit from a sharp travel uptic...
Taiwan’s president emphasizes arms sales as the key deterrent to conflict, while Trump questions ongoing support, tri...
NextEra Energy is pursuing a $67 billion all-stock deal to buy Dominion, aiming to create the world’s largest utility...
Mortgage applications fall 2.3% last week as borrowing costs move higher, signaling a cooling in home-purchase activi...
Solana is often pitched as a blockchain that outpaces and underprices Ethereum. This article digs into why those adva...